Revolution Medicines, Inc. (RVMDW) Net margin 2018–2023
Revolution Medicines, Inc. (RVMDW) net profit margin by fiscal year — reported net income divided by reported revenue.
-3765.1%FY2023 · since FY2018: -207.2% → -3765.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -3765.1% | -3061.3 pp |
| FY2022 | -703.8% | -67.5 pp |
| FY2021 | -636.3% | -384.6 pp |
| FY2020 | -251.6% | -156.4 pp |
| FY2019 | -95.2% | +112.0 pp |
| FY2018 | -207.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice